1. Clinical differentiation and mutation spectrum of chylomicronemia patients in a German outpatient clinic. (December 2020) Authors: Bardey, F.; Rieck, L.; Spira, D.; März, W.; Schwab, S.; Binner, P.; Bobbert, T.; Spranger, J.; Steinhagen-Thiessen, E.; Demuth, I.; Kassner, U. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New data of the treatment with bempedoic acid in clinical routine. (August 2022) Authors: Schumann, F.; Steinhagen-Thiessen, E.; Bobbert, T.; Kassner, U. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Short Report Of A Longterm Outcome Of A Patient With Lysosomal Acid Lipase Deficiency And First Results After Initiation Of Treatment With Sebelipase Alfa. (August 2019) Authors: Kassner, U.; Soll, D.; Hollstein, T.; Spira, D.; Bobbert, T.; Steinhagen-Thiessen, E. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment of therapy-refractory hypercholesterolemia with proprotein convertase subtilisin/kexin type 9 antibodies (PCSK9-I) in cardiovascular high risk patients – effectivity and safety in clinical routine. (September 2016) Authors: Hollstein, T.; Spira, D.; Buchmann, N.; El-Zidy Ibrahim, N.; Bobbert, T.; Steinhagen-Thiessen, E.; Kassner, U. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗